Lv11
68 积分 2026-06-27 加入
Generic Controlled-Release Budesonide in IgA Nephropathy – A Single Center Retrospective Study
1小时前
待确认
Real-world multicenter evidence on Nefecon for attenuating proteinuria and kidney function decline in IgA nephropathy
1小时前
已完结
慢性肾脏病的流行病学调查现状
2个月前
已完结
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
2个月前
已完结
皖公网安备34019202002308
